
View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1. Identification of a Nos Response Element in the CycB
3' UTR. (A) Drawing to scale of the CycB
3' UTR and the fragments used in the experiments below. The critical
regulatory region (fragment E in red) is present in the maternal mRNA isoform
but spliced out of the zygotic isoform (dashed line). Numbers identify the
3' UTR nucleotides present in each fragment. Note that fragment F
contains 25 nt encoded by genomic DNA downstream of the polyadenylation and
cleavage site. (B) Gel mobility shift experiments with RNA bearing the
hb NRE or various fragments of the CycB 3' UTR. On the
left, RNA was incubated with embryonic extract prepared as described
(Murata and Wharton, 1995 ). On
the right, the Pum RBD was incubated at concentrations of 0, 0.14, 0.42 and
1.3 µM in lanes 1-4 of each titration. The figure is a composite of two
different gels. (C) Drawing of the region spanning fragments D and E,
where each dot represents a potential Pum-binding site (UGU trinucleotide).
The functionally defined 50 nt CycB NRE (black box, nts 594-643 of
the 3' UTR) contains two such UGU trinculeotides (red dots, see the
sequence in E). Repression in the PGCs at stage 4 for various derivatives is
indicated to the right. (D) Accumulation of CycB (green) in stage 4
embryos in which the PGCs are marked by accumulation of Vasa (red), detected
by immunofluorescence and confocal microscopy. In these and all subsequent
images, repression of CycB mRNA causes the pole cells to appear red,
whereas de-repression results in colocalization of CycB and Vasa, causing the
pole cells to appear yellow-orange. Embryos are either from
w1118 (wt) nosBN, or
pumET3/pumMsc females, or
CycB2/+ females that also bear the indicated CycB
transgene. (E) Sequence of the 50 nt CycB NRE (nts 594-643 of
the 3' UTR). Binding sites for Nos and Pum are inferred from experiments
with purified proteins and a collection of mutant RNAs. Supporting data is
presented in Fig. S3 of the supplementary material.
|